Contact info:
- Within USA, US territories & Canada 866-258-7741. Outside USA, US territories & Canada 201-680-6578. www.computershare.com.
- Notice of Conversion Privilege for 2.25% Convertible Debentures.
- Notice of Effective Date for 2.25% Convertible Debentures.
... regulatory activities. Contacts: Investors – Patty Eisenhaur, AMRI Investor Relations, 518-512-2936. Media: Gina Rothe, AMRI Communications, 518-512-2512.
These reports include company annual reports (10K, 10Q), news updates (8K), investor ... AMRI (NASDAQ: AMRI) today announced the appointment of David ...
Ready to develop a successful partnership? Let's Get Started · Privacy Policy · Terms of Use · Contact Us · Investor Relations. © Albany Molecular ...
Information on acquisition, funding, investors, and executives for AMRI Hospitals. Use the PitchBook Platform to explore the full profile.
Missing: relations | Show results with:relations
Jun 5, 2017 · ... report. Contact: Patty Eisenhaur. Head of Investor Relations. 518.512.2261. investorinfo@amriglobal.com. Item 9.01 - Financial Statements and ...
Join Curia at CPhI North America, the premier event for pharmaceutical professionals worldwide. Connect with us at booth 1021 to discuss your drug development ...
Net assets increased by 4.09% to 298.98M and EPS decreased from -0.07 to -1.83. AMRI's Investor Relations. Income StatementBalance SheetCash Flow Statement.
Oct 5, 2023 · DIRECTORS' ANNUAL REPORT for the financial year ended 31 December 2022. Page 37. 35. AMRI ANNUAL REPORT 2022–2023. The balance held as ...
Financial Services & Investing · General Business. Close ... AMRI (NASDAQ: AMRI) today reported financial and ... For Public Relations · For IR & Compliance · For ...